2.12
price up icon0.00%   0.00
after-market Dopo l'orario di chiusura: 2.05 -0.07 -3.30%
loading

Dare Bioscience Inc Azioni (DARE) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
183.27%
-0.0212
0.0254 -0.0636 0.0417 0.0224
Operating Expenses
17.36%
3.8066
4.6065 5.3246 4.723 7.3819
Benefits Costs and Expenses
3.9953
- 4.0618 - -
Costs And Expenses
17.36%
3.8066
4.6065 -14.07 4.723 7.3819
Operating Income/Loss
16.44%
-3.8278
-4.5811 -5.3882 -4.6813 -7.3595
Income/Loss From Continuing Operations Before Tax
8.26%
-4.0165
-4.3783 -4.1254 0.0417 12.91
Income/Loss From Continuing Operations After Tax
8.26%
-4.0165
-4.3783 -5.5048 -4.7025 12.91
Net Income/Loss
8.26%
-4.0165
-4.3783 -5.5064 -4.7025 12.91
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.28%
8.8712
8.7591 -0.1594 8.5344 8.4112
Diluted Average Shares
1.28%
8.8712
8.7591 -0.1862 8.5344 8.4762
Basic Earnings Per Share
10.00%
-0.45
-0.50 -0.65 -0.55 1.53
Diluted Earnings Per Share
10.00%
-0.45
-0.50 -0.65 -0.55 1.52
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):